Marshall Wace’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Marshall Wace’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-66,135	Closed	-$2.23M	–	3671
2021 Q2	$2.23M	Buy	+66,135	New	+$1.69M	0.01%	1353
2021 Q1	–	Sell	-56,991	Closed	-$1.64M	–	3047
2020 Q4	$1.64M	Buy	+56,991	New	+$1.43M	0.01%	1028

Marshall Wace's CNST Position: Q3 2021 in Review

Marshall Wace sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 66,135 shares — an estimated $2.23M sold.

Marshall Wace first reported a position in CNST in Q4 2020 and held it in 2 quarters. The position peaked at $2.23M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Marshall Wace reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Marshall Wace sold 66,135 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $2.23M.
Marshall Wace first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2020 and held it in 2 quarters.
Marshall Wace's Constellation Pharmaceuticals, Inc. position peaked at $2.23M in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.